(Q36650691)

15 August 2017

1 reference

title

Protease inhibitors and their peptidomimetic derivatives as potential drugs (English)

1 reference

15 August 2017

Slavko Komarnytsky

2

0 references

author name string

Georgie Fear

series ordinal

1

1 reference

15 August 2017

Ilya Raskin

series ordinal

3

1 reference

15 August 2017

language of work or name

1 reference

22 September 2006

1 reference

Pharmacology & Therapeutics

15 August 2017

published in

1 reference

15 August 2017

volume

113

1 reference

15 August 2017

issue

2

1 reference

15 August 2017

page(s)

354-368

1 reference

Doxycycline and tissue repair in rats

15 August 2017

cites work

1 reference

12 December 2020

Unraveling the role of proteases in cancer

1 reference

12 December 2020

Marked inhibition of tumor growth in a malignant glioma tumor model by a novel synthetic matrix metalloproteinase inhibitor AG3340.

1 reference

12 December 2020

Treatment with an oral proteinase inhibitor slows gastric emptying and acutely reduces glucose and insulin levels after a liquid meal in type II diabetic patients

1 reference

12 December 2020

Novel roles of protease inhibitors in infection and inflammation

1 reference

12 December 2020

Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers

1 reference

12 December 2020

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation

1 reference

12 December 2020

Design of selective eglin inhibitors of HCV NS3 proteinase

1 reference

12 December 2020

Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial

1 reference

12 December 2020

Antimalarial effects in mice of orally administered peptidyl cysteine protease inhibitors

1 reference

12 December 2020

Oral trypsin inhibitor can improve reflux esophagitis after distal gastrectomy concomitant with decreased trypsin activity

1 reference

12 December 2020

Soybean trypsin inhibitor confers protection against rotavirus infection in infant mice

1 reference

12 December 2020

Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.

1 reference

12 December 2020

Twelve-week monotherapy with the DPP-4 inhibitor vildagliptin improves glycemic control in subjects with type 2 diabetes.

1 reference

12 December 2020

Inhibitors of the proteolytic activity of urokinase type plasminogen activator

1 reference

12 December 2020

Reducing bleeding complications after thrombolytic therapy for stroke: clinical potential of metalloproteinase inhibitors and spin trap agents

1 reference

12 December 2020

Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray-induced transformation in vitro

1 reference

12 December 2020

The interaction of the potato-derived chymotrypsin inhibitor with C3H/10T1/2 cells.

1 reference

12 December 2020

Proteasome inhibitor bortezomib for the treatment of multiple myeloma.

1 reference

12 December 2020

(2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

1 reference

12 December 2020

Quest for selectivity in inhibition of matrix metalloproteinases

1 reference

12 December 2020

Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1.

1 reference

12 December 2020

Impact of protease inhibitors and other antiretroviral treatments on acquired immunodeficiency syndrome survival in San Francisco, California, 1987-1996.

1 reference

12 December 2020

Liquid chromatography-mass spectrometry and liquid chromatography-NMR characterization of in vitro metabolites of a potent and irreversible peptidomimetic inhibitor of rhinovirus 3C protease

1 reference

12 December 2020

Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA.

1 reference

12 December 2020

A novel orally active proteasome inhibitor induces apoptosis in multiple myeloma cells with mechanisms distinct from Bortezomib

1 reference

12 December 2020

Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells

1 reference

12 December 2020

Callysponginol sulfate A, an MT1-MMP inhibitor isolated from the marine sponge Callyspongia truncata

1 reference

12 December 2020

Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumors

1 reference

12 December 2020

Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.

1 reference

12 December 2020

Aprotinin diminishes inflammatory processes

1 reference

12 December 2020

In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease

1 reference

12 December 2020

Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid

1 reference

12 December 2020

Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4)

1 reference

12 December 2020

Bivalirudin: a direct thrombin inhibitor

1 reference

12 December 2020

Non-peptide inhibitors of HCV serine proteinase

1 reference

12 December 2020

RAS inhibition in hypertension

1 reference

12 December 2020

Structure-based development of cathepsin L inhibitors and therapeutic applications for prevention of cancer metastasis and cancer-induced osteoporosis.

1 reference

12 December 2020

2-(2-Hydroxy-3-alkoxyphenyl)-1H-benzimidazole-5-carboxamidine derivatives as potent and selective urokinase-type plasminogen activator inhibitors

1 reference

12 December 2020

Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis

1 reference

12 December 2020

Antimalarial synergy of cysteine and aspartic protease inhibitors

1 reference

12 December 2020

Treatment of acute pancreatitis with protease inhibitors: a meta-analysis

1 reference

12 December 2020

Alpha 1-antitrypsin Pittsburgh (Met358-->Arg) inhibits the contact pathway of intrinsic coagulation and alters the release of human neutrophil elastase during simulated extracorporeal circulation

1 reference

12 December 2020

The uPA/uPA receptor system as a target for tumor therapy.

1 reference

12 December 2020

N-arylaminonitriles as bioavailable peptidomimetic inhibitors of cathepsin B

1 reference

12 December 2020

Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes

1 reference

12 December 2020

ADAMTS-4 (aggrecanase-1): N-terminal activation mechanisms

1 reference

12 December 2020

Selective kallikrein inhibitors alter human neutrophil elastase release during extracorporeal circulation

1 reference

12 December 2020

Battle against malaria could involve anti-HIV drugs

1 reference

12 December 2020

The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.

1 reference

12 December 2020

Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer's disease: prospects, limitations and strategies

1 reference

12 December 2020

Cysteine proteases of malaria parasites

1 reference

12 December 2020

Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3.4A serine protease

1 reference

12 December 2020

Amentoflavone and its derivatives as novel natural inhibitors of human Cathepsin B

1 reference

12 December 2020

Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications

1 reference

12 December 2020

Invasiveness of transformed human breast epithelial cell lines is related to cathepsin B and inhibited by cysteine proteinase inhibitors

1 reference

12 December 2020

Pharmacokinetics and safety of an antirhinoviral agent, ruprintrivir, in healthy volunteers

1 reference

12 December 2020

Protease Inhibitors Prevent the Development of Human Rotavirus-Induced Diarrhea in Suckling Mice

1 reference

12 December 2020

SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells

1 reference

12 December 2020

Peptidyl vinyl sulphones: a new class of potent and selective cysteine protease inhibitors: S2P2 specificity of human cathepsin O2 in comparison with cathepsins S and L.

1 reference

12 December 2020

Treatment of SARS with human interferons

1 reference

12 December 2020

Matrix metalloproteinases: structures, evolution, and diversification

1 reference

12 December 2020

Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.

1 reference

12 December 2020

Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitor

1 reference

12 December 2020

Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat

1 reference

12 December 2020

Cholecystokinin and satiety: current perspectives

1 reference

12 December 2020

Pyrimido[1,2- b ]-1,2,4,5-tetrazin-6-ones as HCMV protease inhibitors: a new class of heterocycles with flavin-like redox properties

1 reference

12 December 2020

Isatin compounds as noncovalent SARS coronavirus 3C-like protease inhibitors.

1 reference

12 December 2020

Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies

1 reference

12 December 2020

Synthesis and structure activity relationships of novel small molecule cathepsin D inhibitors

1 reference

12 December 2020

Blocking effect of a biotinylated protease inhibitor on the egress of Plasmodium falciparum merozoites from infected red blood cells

1 reference

12 December 2020

Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro.

1 reference

12 December 2020

Inhalation of alpha(1)-protease inhibitor in cystic fibrosis does not affect surfactant convertase and surface activity

1 reference

12 December 2020

Oral administration of proteinase inhibitor II from potatoes reduces energy intake in man.

1 reference

12 December 2020

The nutritive quality and the trypsin inhibitor content of soybean flour heated at various temperatures

1 reference

12 December 2020

Peptidomimetic inhibitors of the human cytomegalovirus protease.

1 reference

12 December 2020

In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease

1 reference

12 December 2020

Potato carboxypeptidase inhibitor, a T-knot protein, is an epidermal growth factor antagonist that inhibits tumor cell growth

1 reference

12 December 2020

Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril

1 reference

12 December 2020

Regulation of pulmonary and systemic bacterial lipopolysaccharide responses in transgenic mice expressing human elafin

1 reference

12 December 2020

Picornavirus receptor down-regulation by plasminogen activator inhibitor type 2

1 reference

12 December 2020

Membrane associated proteases and their inhibitors in tumour angiogenesis

1 reference

12 December 2020

Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo

1 reference

12 December 2020

Attenuation of host defense function of lung phagocytes in young cystic fibrosis patients

1 reference

12 December 2020

Procyanidin structure defines the extent and specificity of angiotensin I converting enzyme inhibition

1 reference

12 December 2020

Evolutionary families of peptidase inhibitors

1 reference

12 December 2020

Consumption of diets containing raw soya beans (Glycine max), kidney beans (Phaseolus vulgaris), cowpeas (Vigna unguiculata) or lupin seeds (Lupinus angustifolius) by rats for up to 700 days: effects on body composition and organ weights

1 reference

12 December 2020

Synthesis and biological evaluation of biphenylsulfonamide carboxylate aggrecanase-1 inhibitors

1 reference

12 December 2020

Extracellular proteases as targets for treatment of cancer metastases

1 reference

12 December 2020

Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor

1 reference

12 December 2020

New mechanism-based inactivators of trypsin-like proteinases. Selective inactivation of urokinase by functionalized cyclopeptides incorporating a sulfoniomethyl-substituted m-aminobenzoic acid residue.

1 reference

12 December 2020

In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses

1 reference

12 December 2020

HIV protease inhibitors and atherosclerosis

1 reference

12 December 2020

The role of protease inhibition with emphasis on the effects of inflammation and vascular immune phenomena

1 reference

12 December 2020

Trypsin activation pathway of rotavirus infectivity.

1 reference

12 December 2020

Leucaena leucocephala serine proteinase inhibitor: primary structure and action on blood coagulation, kinin release and rat paw edema

1 reference

12 December 2020

Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines: an important new class of selective synthetic urokinase inhibitor

1 reference

12 December 2020

Selective nonpeptidic inhibitors of herpes simplex virus type 1 and human cytomegalovirus proteases

1 reference

12 December 2020

Inhibitory effect of serine protease inhibitors on neutrophil-mediated endothelial cell injury

1 reference

12 December 2020

Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain

1 reference

12 December 2020

Novel hepatitis C virus protease inhibitors: thiazolidine derivatives

1 reference

12 December 2020

Plasmepsins as potential targets for new antimalarial therapy

1 reference

12 December 2020

Inhibitors of proteases as anticancer drugs.

1 reference

12 December 2020

HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro

1 reference

12 December 2020

The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications

1 reference

12 December 2020

Gateways to clinical trials

1 reference

12 December 2020

Oral anticoagulants in development: focus on thromboprophylaxis in patients undergoing orthopaedic surgery

1 reference

12 December 2020

Protease inhibitors of the sulfonamide type: anticancer, antiinflammatory, and antiviral agents

1 reference

12 December 2020

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

1 reference

12 December 2020

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus

1 reference

12 December 2020

Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study).

1 reference

12 December 2020

Proteinase inhibitors I and II from potatoes block UVB-induced AP-1 activity by regulating the AP-1 protein compositional patterns in JB6 cells

1 reference

12 December 2020

Crystal structure of Dengue virus NS3 protease in complex with a Bowman-Birk inhibitor: implications for flaviviral polyprotein processing and drug design

1 reference

12 December 2020

Cysteine protease inhibitors as chemotherapy: lessons from a parasite target

1 reference

12 December 2020

Serine protease inhibitors block invasion of host cells by Toxoplasma gondii.

1 reference

12 December 2020

Structure-based design of aliskiren, a novel orally effective renin inhibitor

1 reference

12 December 2020

Proteinase inhibitors induce selective stimulation of human trypsin and chymotrypsin secretion

1 reference

12 December 2020

Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients.

1 reference

12 December 2020

Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits

1 reference

12 December 2020

Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C.

1 reference

12 December 2020

Metalloproteinases, inflammation, and rheumatoid arthritis.

1 reference

12 December 2020

Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight.

1 reference

12 December 2020

Protease inhibitors as antiviral agents.

1 reference

12 December 2020

Aprotinin improves kidney function and decreases tubular cell apoptosis and proapoptotic signaling after renal ischemia-reperfusion

1 reference

12 December 2020

Expression and functional properties of antibodies to tissue inhibitors of metalloproteinases (TIMPs) in rheumatoid arthritis

1 reference

12 December 2020

1 reference

12 December 2020

Aprotinin attenuated ischemia-reperfusion injury in an isolated rat lung model after 18-hours preservation

1 reference

12 December 2020

Dipeptidyl peptidase IV inhibitors: how do they work as new antidiabetic agents?

1 reference

12 December 2020

Flavins inhibit human cytomegalovirus UL80 protease via disulfide bond formation

1 reference

12 December 2020

Effects of the Bowman-Birk inhibitor on growth, invasion, and clonogenic survival of human prostate epithelial cells and prostate cancer cells

1 reference

12 December 2020

Apical cell surface expression of rat dipeptidyl peptidase IV in transfected Madin-Darby canine kidney cells

1 reference

12 December 2020

Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor

1 reference

12 December 2020

Acceleration of phagocytosis in human neutrophils incubated with gabexate mesilate

1 reference

12 December 2020

HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus

1 reference

12 December 2020

Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.

1 reference

12 December 2020

Azapeptides structurally based upon inhibitory sites of cystatins as potent and selective inhibitors of cysteine proteases.

1 reference

12 December 2020

Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro

1 reference

12 December 2020

Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds.

1 reference

12 December 2020

Tactics for vascular protection after acute ischemic stroke

1 reference

12 December 2020

Design and therapeutic application of matrix metalloproteinase inhibitors

1 reference

12 December 2020

10.1016/J.PHARMTHERA.2006.09.001

Identifiers

DOI

1 reference

release_7fnx3ypxbzb2fe4h7xlizqkmte

15 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7fnx3ypxbzb2fe4h7xlizqkmte

24 November 2022

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/7fnx3ypxbzb2fe4h7xlizqkmte

24 November 2022

mapped directly with Wikidata item

1 reference